Maurizio Zazzi

40PUBLICATIONS
139CO-AUTHORS
Gene and molecular therapyMedical molecular engineering of nucleic acids and proteinsDisease surveillanceGenomics and transcriptomicsGenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Oct 28, 2026
Virological outcomes, resistance profile and viral evolution of lenacapavir-based regimens in heavily treatment-experienced people: data from the PRESTIGIO Registry.

|Oct 27, 2026
Extensive Proteomic Approach to Assess Protein Alterations in Human Hepatoma Huh7 Cells Infected with West Nile Virus.

|May 13, 2026
HIV-1 Sub-subtype A6 Remains Susceptible to Second-Generation Integrase Inhibitors With Limited Emergence of Resistance in Vitro.

|Feb 24, 2026
Switching to bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and prior resistance mutations. Data from the Italian ARCA cohort: the BIC-BARRIER study. B/F/TAF switch: mutations and outcomes.

Laura Pezzati, Federico Conti, William Gennari

|Sep 24, 2025
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry.

D Armenia, G Marchegiani, V Spagnuolo

|Aug 28, 2025
Correction: Biba et al. A Comparison of Sanger Sequencing and Amplicon-Based Next Generation Sequencing Approaches for the Detection of HIV-1 Drug Resistance Mutations. Viruses 2024, 16, 1465.

Camilla Biba, Lia Fiaschi, Ilenia Varasi

Pageof 7

Frequent Collaborators

22 joint publications

Ilaria Vicenti

8 joint publications

Francesco Saladini

7 joint publications

Filippo Dragoni

5 joint publications

Federica Giammarino